|
1 |
The 2025 ATA guidelines for differentiated thyroid Cancer - Ten years of professional debate and measured progress
Enthalten in European journal of nuclear medicine and molecular imaging 12.11.2025: 1-4
|
|
|
2 |
Gesund werden mit EMDR
Richter, Anna-Konstantina. - Gießen : Psychosozial-Verlag, [2024], Originalausgabe
|
|
|
3 |
Gesund werden mit EMDR
Richter, Anna-Konstantina. - Gießen : Psychosozial-Verlag, 2024
|
|
|
|
4 |
Connectivity based on glucose dynamics reveals exaggerated sensorimotor network coupling on subject-level in Parkinson’s disease
Enthalten in European journal of nuclear medicine and molecular imaging 17.6.2024: 1-13
|
|
|
|
5 |
Diagnostic value of FDG-PET/CT in the diagnostic work-up of inflammation of unknown origin
Enthalten in Nuklearmedizin Bd. 62, 2023, Nr. 01: 27-33
|
|
|
|
6 |
The effect of surveillance for differentiated thyroid carcinoma in childhood cancer survivors on survival rates
Heinzel, Alexander. - Aachen : Universitätsbibliothek der RWTH Aachen, 2022
|
|
|
|
7 |
Thyroglobulin and thyroglobulin antibodies: assay-dependent management consequences in patients with differentiated thyroid carcinoma
Enthalten in Clinical chemistry and laboratory medicine Bd. 60, 2022, Nr. 5: 756-765. 10 S.
|
|
|
|
8 |
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
Konijnenberg, Mark. - Würzburg : Universität Würzburg, 2021
|
|
|
|
9 |
Questions and controversies in the clinical application of tyrosine kinase inhibitors to treat patients with radioiodine-refractory differentiated thyroid carcinoma: expert perspectives
Verburg, Frederik Anton. - Freiburg : Universität, 2021
|
|
|
|
10 |
Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives
Enthalten in Hormone and metabolic research Bd. 53, 2021, Nr. 03: 149-160
|
|
Administration
